ANIXA BIOSCIENCES INC - Stock Price History | ANIX

Historical daily share price chart and data for ANIXA BIOSCIENCES INC since 2023 adjusted for splits. The latest closing stock price for ANIXA BIOSCIENCES INC as of February 03, 2023 is 4.57.
  • The all-time high ANIXA BIOSCIENCES INC stock closing price was 7.14 on March 17, 2021.
  • The ANIXA BIOSCIENCES INC 52-week high stock price is 6.25, which is 36.8% above the current share price.
  • The ANIXA BIOSCIENCES INC 52-week low stock price is 2.30, which is 49.7% below the current share price.
  • The average ANIXA BIOSCIENCES INC stock price for the last 52 weeks is 3.87.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ANIXA BIOSCIENCES INC Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 3.7438 3.0200 6.1500 2.5000 4.2500 43.10%
2021 4.3934 3.2700 7.1400 2.8800 2.9700 -3.26%
2020 2.5226 3.0000 4.0600 1.3500 3.0700 -6.40%
2019 4.2042 3.9500 5.5300 2.7800 3.2800 -16.75%
2018 3.9032 2.3400 6.5900 2.3400 3.9400 66.95%
2017 2.3369 5.2990 5.3500 0.6001 2.3600 -56.30%
2016 3.7013 3.0400 6.7500 1.8800 5.4000 79.40%
2015 4.0311 3.8000 5.9000 2.3700 3.0100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.141B $0.001B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00